Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

<p>This research programme investigated the expression of prolyl hydroxylase (PHD) proteins in rodent tissues. The importance of PHD enzymes lies in their ability to render oxygen sensitivity to Hypoxia inducible factor (HIF), the principal mediator of intracellular oxygen homeostasis. The fir...

Полное описание

Библиографические подробности
Главный автор:	Wijeyekoon, JB
Другие авторы:	Pugh, C
Формат:	Диссертация
Язык:	English
Опубликовано:	2013
Предметы:	Medical Sciences Clinical laboratory sciences

Схожие документы

Regulation of HIF: prolyl hydroxylases.
по: Stolze, I, и др.
Опубликовано: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
по: Chowdhury, R, и др.
Опубликовано: (2016)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
по: Rasheduzzaman Chowdhury, и др.
Опубликовано: (2016-08-01)

Tolerance in renal transplantation: is mixed chimerism the missing link?
по: Janes, S, и др.
Опубликовано: (2009)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
по: McNeill, L, и др.
Опубликовано: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
по: Tuckerman, JR, и др.
Опубликовано: (2004)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
по: Mole, D, и др.
Опубликовано: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
по: Schlemminger, I, и др.
Опубликовано: (2003)

Studies on HIF hydroxylases
по: Webb, J
Опубликовано: (2008)

Cortical dynamics subserving visual apparent motion
по: Ahmed, B, и др.
Опубликовано: (2008)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
по: Moritz J. Strowitzki, и др.
Опубликовано: (2021-04-01)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
по: Holt-Martyn, JP, и др.
Опубликовано: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
по: Cockman, M, и др.
Опубликовано: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
по: Matthew E Cockman, и др.
Опубликовано: (2019-09-01)

Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners
по: Hongyan Deng, и др.
Опубликовано: (2024-06-01)

The role of CCL25 and CCR9 in intestinal inflammation
по: Wendt, E, и др.
Опубликовано: (2013)

Adaptive changes of influenza virus A/H5N1 neuraminidase in vitro and in vivo
по: Le Nguyen, T
Опубликовано: (2014)

Angiogenesis in human lung tumours
по: Ferguson, ML
Опубликовано: (2008)

Editorial commentary: Understanding BCG is the key to improving it
по: McShane, H
Опубликовано: (2014)

Human T-lymphotropic virus type 1(HTLV-1) associated infective dermatitis
по: Hlela, C
Опубликовано: (2011)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
по: Chan, M, и др.
Опубликовано: (2016)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
по: Yeh, TL, и др.
Опубликовано: (2017)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
по: Maria Savyuk, и др.
Опубликовано: (2020-07-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
по: Andrey A. Poloznikov, и др.
Опубликовано: (2021-01-01)

Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme
по: Holt-Martyn, J
Опубликовано: (2018)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
по: Flashman, E, и др.
Опубликовано: (2010)

Probing the molecular basis of melanopsin induced light sensitivity
по: Vachtsevanos, AN
Опубликовано: (2012)

Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury
по: Zhao-Ying Ding, и др.
Опубликовано: (2022-03-01)

HR23B, a biomarker for HDAC inhibitors
по: Khan, OA
Опубликовано: (2013)

Risk factors for haemorrhage in patients with haematological malignancies
по: Estcourt, LJ
Опубликовано: (2014)

Transcription regulation of Nrp1 during endothelial cell differentiation
по: Zhao, Z
Опубликовано: (2014)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
по: Chowdhury, R, и др.
Опубликовано: (2013)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
по: Lippl, K
Опубликовано: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
по: Masson, N, и др.
Опубликовано: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
по: Takahiro Kambara, и др.
Опубликовано: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
по: Kiichi Hirota
Опубликовано: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
по: Kilian B. Kennel, и др.
Опубликовано: (2022-11-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
по: Savyuk, Maria Olegovna, и др.
Опубликовано: (2021-05-01)

Evaluation of strain circulation and the epidemiology of enteric fever caused
по: Karkey, A, и др.
Опубликовано: (2012)

International best practice: Understanding the core difference between medical laboratory science and clinical laboratory medicine in Nigeria
по: Felix Archibong, и др.
Опубликовано: (2021-01-01)